50th ASH Annual Meeting and Exposition (December 6 - 9, 2008): Acute Myeloid Leukemia

Before you can access ASH's online program, you must agree to the following:

Abstracts submitted to the ASH Annual Meeting are considered embargoed from the time of submission.
For the research and study to be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented about the research and/or study at the annual meeting, may not be made public before the abstract has been published/presented at the ASH annual meeting.

Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Acute Myeloid Leukemia

Saturday, December 6, 2008: 9:30 AM-11:00 AM

2001-2003-2005 - West (Moscone Center)

Sunday, December 7, 2008: 7:30 AM-9:00 AM

2001-2003-2005 - West (Moscone Center)

Molecular Genetic Pathways as Therapeutic Targets in AML

Torsten Haferlach, MD

MLL Munich Leukemia Laboratory GmbH, Munich, Germany

Curative Strategies in APL

Martin S. Tallman, MD

Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL

Alternative Strategies for Hematopoietic Cell Transplantation in AML

Frederick R. Appelbaum, MD

Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA

See more of: Education Program

<< Previous Session | Next Session >>